- CJC-1295 (Without DAC)– A short-acting GHRH (Growth Hormone Releasing Hormone) analog, studied for stimulating the pituitary to release natural growth hormone with a relatively short half-life (minutes to hours).
- Ipamorelin (IPA)– A selective GHRP (Growth Hormone Releasing Peptide) analog, studied for stimulating GH release through ghrelin receptor activation with minimal impact on cortisol or prolactin.
- Synergistic Action– The combination of a GHRH analog (CJC-1295 w/o DAC) and a GHRP analog (Ipamorelin) produces amplified GH release in preclinical studies, mimicking natural pulsatile growth hormone secretion.
- Muscle Growth & Recovery– Explored for enhancing lean muscle mass, recovery, and protein synthesis in experimental models.
- Anti-Aging Research– Studied for restoring youthful GH/IGF-1 profiles, supporting vitality and longevity.
- Metabolic Support – Research suggests potential benefits in fat loss, improved sleep quality, and overall metabolic regulation.
